News Release More 2018年11月20日 Launch of "Beova® Tablets 50mg" for the Treatment of Overactive Bladder 2018年11月 5日 Summary of Consolidated Financial Results (For the Second Quarter Ended September 30, 2018) [Japanese Standard] 2018年11月 5日 Second Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2019 2018年11月 5日 Notice Regarding the Cancellation of Treasury Stock 2018年11月 2日 Revision of Consolidated Financial Forecasts 2018年9月27日 Notice on Results and Completion of Acquisition of Treasury Stock through Off-Floor Trading for Purchase of Treasury Stock (ToSTNeT-3) and Change to Major Shareholder 2018年9月26日 Notice of Acquisition of Treasury Stock and Purchase of Treasury Stock by Off-Floor Trading for Purchase of Treasury Stock (ToSTNeT-3) 2018年9月21日 Kyorin Receives Marketing Approval in Japan for｢Beova Tablets 50mg｣ for the Treatment of Overactive Bladder Latest IR Events More Second quarter results of fiscal year ending March 31,2019 Summary of consolidated Financial Results [ PDF 62.5 KB ] Supplementary Information [ PDF 377.6 KB ] Presentation document（Nov 6, 2018） [ PDF 1.2 MB ] Top Message Products Under Development IR Events Financial Information Financial Highlights Financial Indicators Business Segment/Main Products Cash Flows Capital Investment/Depreciation/R&D Costs Download Financial Data IR Library Summary of ConsolidatedFinancial Results/Presentation Document Annual Report Stock Information Shareholder Return/Dividends General Information Stock Quote Business Risks Disclaimer FAQ Disclosure Policy
Downloads Downloads